Aenova is a leading CDMO provider for the pharmaceutical and healthcare industries. The company offers comprehensive services from development to commercialization across all common dosage forms, including highly potent APIs. With 14 manufacturing sites and 7 development centers in Europe and the US, Aenova supports customers worldwide with tailored solutions, high reliability, and accelerated time to market.
The AFSSI, the French Association of Service and Innovation Companies for the Life Sciences has the desire to unite French companies of services and technological innovation in the strategic field of Life Sciences.
AFSSI challenges are driven by the vision of life science companies as top players in international competition. AFSSI works toward enriching the Life sciences industry with networking, partnering and education opportunities
Wallonia stands among Europe’s most dynamic life sciences ecosystems. Driven by the BioWin cluster and supported by AWEX, it unites biotech, medtech, and radiopharma companies, top universities, hospitals, and financing networks. From research to industrial production, this “Fantastic Ecosystem” combines excellence, innovation, and strategic proximity, positioning Wallonia as a global hub for biomanufacturing and future medicine.
Aliri is the strategic combination of three renowned legacy laboratories, Pyxant Labs, Tandem Labs, and ImaBiotech.
We are focused on providing pharma and biotech companies with bioanalytical lab, spatial bioanalysis, and spatial biology solutions. Laboratory is equipped with advanced platforms and ready to use methods, including QMSI, CyTOF, Visium & Visium HD, hybridization-based extraction, LC-MS, HRAM-MS, LC-HR-MS and our powerful proprietary AI workflow.
Anydiag (formerly Vebio) provides veterinary biological analysis services, both for diagnostic purposes and GLP regulatory studies (pharmaceutical products and medical devices).
GLP accreditated from both ANSES and ANSM (as well as CIR), we are dedicated to supporting our clients throughout their projects by providing the highest standards of veterinary biological analysis and scientific expertise, ensuring precision, compliance, and trust in every result.
Arizona has been a leading player in commercial and office real estate regeneration across Greater Paris for over 20 years.
The company is now broadening its scope to include industrial and R&D facilities.
Arizona is developing BOOST CAMPUS, a future hub for industry and science, on the former Sanofi site in Chilly-Mazarin and Longjumeau, acquired in mid-2025.
Located at the heart of the Paris-Saclay innovation ecosystem, BOOST CAMPUS covers 16 hectares and enjoys a strategic location with direct access to public transport, just minutes from the Massy hub and Orly International Airport.
The project features 28,000 m² of fully equipped laboratories ready to host companies in biotech, bioproduction, techbio, foodtech, and medtech.
Artialis is a European R&D hub based in Liège, Belgium, offering end-to-end, customized solutions for evidence generation from bench to market. With a strong passion and proven expertise in healthy aging, Artialis provides comprehensive R&D services in preclinical, clinical, and biotesting research.Our mission is driving scientific innovation by helping companies develop products that promote healthy, active aging.
Aseptic Technologies, member of SKAN, is a global leader in aseptic processing and clean manufacturing solutions for the pharma and biotech industries.
We specialize in advanced fill & finish systems, isolator technologies, and custom single-use assemblies, supported by in-house clean injection molding in ISO-certified environments. From development to commercial production, we deliver integrated, ready-to-use solutions that ensure sterility, compliance, and process efficiency.
As a competitiveness cluster labeled by the French Ministry of Economy and Finance, Atlanpole Biotherapies connects over 200 stakeholders :companies, researchers, and healthcare professionals with a shared goal: patient benefit.
Focused on innovative drugs, medical devices, and digital health tools, we drive the HealthTech sector in Western France and beyond.
Bambino Gesù Children’s Hospital, owned by the Holy See, is Europe’s largest pediatric care and research center. With six sites in Italy and 627 beds (40 in intensive care), it was founded in 1869 and became an IRCCS in 1985. Renowned for transplants, cardiology, neuroscience, oncology, and global research (1,091 papers in 2023), it welcomes children and families from around the world.
Located in the heart of Europe, BioPark Charleroi is a leading life sciences hub uniting 100+ companies, 3,300 experts and top research institutes. At the crossroads of biotech, medtech and advanced therapies, and with 37,500 m² of world-class incubator facilities, it offers the ideal environment to move health innovations from lab to patient. BioPark Charleroi: the place to start. To connect. To grow.
Based in Eastern France, the BioValley France cluster brings to the health sector its unique expertise and personalized support around 4 fields of expertise: Drugs and Innovative Therapies, E-health, Medical Technologies and Diagnosis. BioValley France has built a powerful community in order to deploy a strong network mixing academics and industrials in the health sector: more than 250 members and partners have decided to join the Cluster in order to share, exchange and develop tomorrow’s innovation in the best conditions. BioValley France offers services in: Business Competitiveness, Innovative Project, International Relations, Visibility and Influence.
Brand Institute is the global leader in brand name and identity development. For over thirty years, we have been providing a broad portfolio of branding and naming-related services, including name development, trademark searches, market research, regulatory services, and visual identity solutions.
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a team of 2,000 experts located in North America and Europe, Cambrex offers a range of specialized drug substance technologies to support biopharma companies with high-quality API for clinical development to commercial.
CARBOGEN AMCIS provideS drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) – as well as drug products for preclinical studies, clinical trials and commercial use.
Carla Biotherapeutics is a preclinical stage company advancing lead programs targeting hematological malignancies and solid tumors. We are advancing a proprietary CAR-T platform plug-and-play technology to rapidly and efficiently develop precision medicines for severe and aggressive diseases.
Carnot France Futur Elevage is a french public research network, certified by the french ministry of research, that provides R&D competences to livestock farming sector businesses, including animal health, genetic selection, animal nutrition, socio-economic changes in the livestock industry, and livestock farming practices.
The main objectif of Carnot France Futur Elevage is to develop public-private partnership in order to support innovations for tomorrow’s sustainable breeding.
Casalonga, one of the oldest IP law firms in Europe, is strategically based in the major jurisdictions with offices in Paris, Munich, Düsseldorf, Alicante. Our full-service IP firm combines attorneys-at-law, patent and trademark attorneys. We offer technical and legal counselling in all categories of IP rights (patents, trademarks, designs) and related legal areas, from prosecution and strategic counseling to litigation, in all technical fields including Pharma, Biotech, Healthtech, Medtech, AI
The CMMI is an integrated preclinical imaging facility providing services and training to academic and industrial partners. Our multidisciplinary team offers a wide range of services covering the entire workflow: sample preparation, image acquisition and analysis. Created jointly by ULB and UMONS, the CMMI is located in the Biopark Charleroi Brussels South, a site that hosts two academic institutes and numerous companies active in the field of life sciences.
Centro Cardiologico Monzino, recognized in 1992 by the Italian Ministry of Health as an IRCCS, is Europe’s first and only institute entirely dedicated to cardiovascular research and care. It performs over 6,000 surgeries, 80,000 specialist visits, and 98,000 diagnostic tests yearly, integrating research and clinical practice to rapidly translate scientific advances into improved prevention, diagnosis, and treatment.
Your innovation, our mission: CER Groupe, a GLP-certified partner, provides end-to-end support from lead discovery to preclinical stages. Flexible and collaborative in early phases, rigorous and reliable in toxicology, it secures your projects with advanced analytical platforms. Vaccines, immunotherapies, cell and gene therapies: we transform your ideas into solutions ready for the clinic.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts:
• Research Models and Services and Cell Sourcing for GMP Human Cells
• Discovery Services, Safety Assessment, and Laboratory Sciences
• Biologics Testing, CGT CDMO, and QC Microbial Solutions
Clinglobal is a CRO group dedicated to providing solutions to the bioscience R&D sector. From our facilities in Europe, North America, and Africa, we offer preclinical and lab clinical studies in research, companion and production animals, animal clinical and comparative medicine field studies, data management and statistical analysis, histopathology, molecular biology, microbiology, clinical pathology and immunology, product development, regulatory affairs, and quality assurance consultancy.
Clubster NHL – Nutrition, Health, Longevity – is a French competitiveness cluster federating 300 members in the Nutrition, biotechnology and health sectors. We foster collaboration between academia, private companies (start-up, SMEs and large companies), clinicians and final users. Our aim is to help our members to design, develop and finance their innovative products and processes. The activity encompasses the ONE HEALTH concept, close relation between human, animal and plant health.
Clust-ER Health Emilia-Romagna is a key player in the regional innovation ecosystem, supporting companies, research centers, hospitals and institutions in networking, sharing skills, ideas and resources to boost competitiveness. The Bio Hubs Network will boost the regional leadership in developing solutions with transformative potential in health and life science’s sectors, such as pharma, regenerative medicine and digital health.
bioPmed is the Innovation Cluster dedicated to Human Health and Life Sciences in Piedmont Region (Italy). It is managed by Bioindustry Park and aggregates more than 90 members among which start-ups, small and big enterprises, foundations, associations, universities and Local Healthcare Units. bioPmed’s role is to foster connections among its members and field experts, support innovative projects from the idea to the market and promote their global visibility.
CoCEPTIO is an engineering and maintenance company whose mission is to provide “tailor-made” engineering and maintenance solutions with a strong focus & experience in Life Sciences Industry, especially in controlled and complex environments.
Our key strengths are our process, technical and regulatory expertises, the passion and commitment of our employees, and the digitalization of our services.
Collaborative Drug Discovery (CDD) provides intuitive software for biologists and chemists in academia, biotech, and pharma. Its flagship product, CDD Vault, enables secure organization, analysis, and sharing of biological and chemical data. Researchers use it to register entities, manage assays, track inventory, analyze SAR, and capture experiments in an ELN. Founded in 2004, CDD supports thousands of scientists worldwide. Learn more at www.collaborativedrug.com.
Delpharm is a worldwide leader in contract manufacturing and development of medicines.
As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules.
Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations.
Dev4All, créé par 4P-Pharma, est un booster de R&D dédié à l’innovation biomédicale et vétérinaire. Nous proposons les meilleures options de développement préclinique pour transformer les découvertes précoces en solutions thérapeutiques concrètes. Grâce à une approche flexible et collaborative, nous construisons des partenariats durables pour accélérer la traduction des innovations vers la clinique, en santé humaine comme animale.
Di&Care is a French company based in Lille, founded in 2023. It is dedicated to the development and commercialization of digital therapeutics in the fields of sleep and mental health. Our treatments are built upon evidence-based therapies that represent the current standards of care for these conditions.
Disruptive Technologies is a Norwegian company that creates tiny wireless sensors and world-class IoT infrastructure that make it easy to collect data from assets. Our easy-to-use, robust, and affordable sensors integrate seamlessly into any environment. We create solutions with our partners that bring insight into applications for temperature monitoring/cold chain monitoring in healthcare & food and various other applications, driving efficient, responsible, and sustainable operations.
DRUGABILIS is an established preclinical CRO specialized in assessing the pharmaceutical drugability of early R&D compounds, including cytotoxic drugs. Our expertise includes Early Formulation, from animal formulation (efficacy, PK, Tox) to early clinical formulation feasibility assessment (oral low soluble, injectable, topical) and API Solid Form Characterization and Optimization (salts, polymorphs). With about 300 clients supported over 21 years, our experience often makes the difference !
ERBC is a leading preclinical CRO specializing in safety assessment—including safety pharmacology, genetic toxicology, in-vitro and in-silico toxicology, general toxicology, juvenile and reproductive & developmental toxicology—along with pharmacokinetics, bio-analytics, and translational research. Committed to scientific excellence and regulatory compliance, ERBC partners with pharmaceutical, biotech, chemical, and medical device companies to de-risk their development programs and advance human health.
EREA provides a full range of isolators, RABS, laminar flow components, biosafety cabinets, transfer trolleys, and loading/unloading systems for the pharma and biopharma industries. With decades of expertise, EREA delivers tailor-made, GMP-compliant solutions that combine safety, efficiency, and energy savings. Installed worldwide, its technologies support scale-up, time-to-market acceleration, and sustainable operations to help clients achieve better outcomes.
Eurasanté is a development agency dedicated to tech transfer and business development in life sciences sector in Northern France region. Our experienced project managers help researchers, startups and companies with their development projects. To do so, Eurasante provides many services such as real estate, fundraising, recruitment and business development. It also promotes the Eurasante Bio-business Park, which already hosts 12 hospitals, 4 universities, 8 specialised schools and more than 200 companies. It benefits from an exceptional location at the heart of Europe.
Eurofins ADME BIOANALYSES services: Small & Large Molecule Bioanalyses, Biomarkers & Metabolites, Method Development & Validation, ADME, PK/PD, Discovery, Pre-Clinical & Clinical, Topical Product Development.
Eurofins CDMO services: Preformulation, Formulation Development, DP Manufacturing, Clinical Trial Supply and Logistics, CMC/RA
Eurofins OPTIMED services: Protocol Development & Study Design, Regulatory Analysis / Submission, Site and Trial Monitoring & Management, Bioanalysis, Biometr
Eurofins BioPharma Product Testing France, leader in testing and analysis services for the pharmaceutical and biotechnology industries, offers a complete range of quality control, analytical development and research services in the pharmaceutical products sector. With in-depth expertise and high-performance facilities, the company helps customers to guarantee the safety, quality and regulatory compliance of their products, contributing to the advancement of health and medical research.
EuroscreenFast is a pioneer in GPCR science for more than 30 years, offering over 1,000 functional assays (more than 530 GPCR and other targets) and an impressive deorphanisation track record with the identification of 17 natural receptor-ligand pairs. Custom assay development and specialised tools to bridge the gap between in vitro and in vivo data are even more reasons why therapeutic developers worldwide know that EuroscreenFast is the unrivalled GPCR development partner.
Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milano is a general hospital and a IRCCS – Institute for Research, Hospitalization and Health Care. In addition to care, it carries out biomedical and health research activities of clinical and translational nature, to have a concrete impact on patients’ health. The research is conducted in different fields of medicine (neurology, cardiology, transplantation and hematology, gynecology, neonatology, geriatrics and rare diseases).
GAC Group supports companies and territories in securing and structuring funding for their innovative projects. As a key player within the innovation ecosystem, the firm leverages tax incentives (R&D Tax Credit, Innovation Tax Credit, IP Box), public grants (Bpifrance) and European funding to accelerate sustainable growth and enhance economic and environmental performance.
GemPharmatech is a global CRO that provides genetically engineered mouse models and preclinical research services to the scientific community. We carry over 25,000 models including KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice, and continually expand our library to assist our customers in achieving their research goals. To further support our customers, we also offer custom model generation, breeding, and compound efficacy testing in our offices across China and the US.
GenoSafe provides analytical testing services for the evaluation of quality, safety and efficacy of Advanced Therapy Medicinal Products including QC testing, preclinical sample and clinical sample analysis. GenoSafe brings more than 20 years of experience in the development, qualification and validation of key analytical methods for product and sample testing.
Genopole is France’s leading biocluster for biotechnology and life sciences. Located near Paris, it hosts 78 companies and 16 research labs working in genomics, bioinformatics, and bioproduction. Genopole supports startups and fosters collaborations between academia and industry to accelerate innovation from research to market.
As a key player in the Paris-Saclay innovation ecosystem, Genopole promotes cross-sector collaborations in health, bioeconomy, and sustainable industries.
Hamamatsu Photonics is a world leader in manufacturing optoelectronic components, modules and systems. We continue to stay a step ahead through our sensors, detectors and imaging systems, which are designed to cover the entire optical spectrum to target the most demanding of applications.
Present across many industries, our photonic solutions are found in the medical, automotive, science research, environmental and analytical industries.
The Henry Royce Institute (Royce) is the UK’s national centre for advanced materials research and innovation. Serving as the front door to the UK materials community, Royce connects academia, industry and the public to world leading facilities, expertise and collaboration opportunities.
We provide open access to over £200 million of state-of-the-art equipment and infrastructure, supporting the broad materials community – from academic researchers to SMEs and multinational companies.
We are a French biotech specializing in oligonucleotide therapeutics, offering an end-to-end drug discovery platform from design to manufacturing transfer. Our expertise spans ASO, siRNA, miRNA, Decoy across multiple therapeutic areas. With proprietary technologies and flexible collaboration models, we support external partners through fee-for-service or co-development. Focused on innovation and speed, we provide customized solutions to accelerate the development of next-generation therapeutics.
ILONOV is a french-swiss biotech company developing first-in-class biotherapies for the treatment of diabetes and metabolic disorders.
Our innovation is rooted in the discovery of the therapeutic potential of a unique myokine, ILV-001, secreted by human skeletal muscle during physical activity. Preclinical studies conducted ex vivo and in vivo have demonstrated that our drug candidate restores insulin secretion and the extracellular matrix environment of pancreatic islets. ILV-001 acts through novel signaling pathways, and the biology of its target receptors remains largely unexplored. This opens opportunities for the development of multiple future therapeutics, while supporting a robust and defensible patent strategy for ILONOV.
Established in 2000 by leading higher education and research institutions along with major industrial players in the region, IncubAlliance Paris-Saclay is accredited by the French Ministry of Higher Education and Research and chaired by Paris-Saclay University.
A team of experts supports deep tech startups from their first steps to consolidation, through specialized programs meticulously designed to facilitate the transition from technology to startup.
InhaTarget Therapeutics is a spin-off company from the University of Brussels (ULB) – Belgium, dedicated to the early development and clinical validation of innovative treatments of pulmonary diseases by inhalation, with a first focus on lung cancer. The company was established in August 2019 and brings together strong complementary expertise in drug formulation, inhalation delivery, immunology, preclinical development and clinical operations.
IRCCS INRCA (Istituto Nazionale di Riposo e Cura per Anziani) is Italy’s national institute specialising in geriatric care and ageing-research. Combining clinical excellence with translational science, we pursue innovations in healthy longevity, frailty prevention and age-friendly technologies. Our mission: to enhance autonomy and value in later life through integrated care and evidence-based research
The Giovanni Paolo II Tumor Institute in Bari (IRCCS) is dedicated to cancer diagnosis, treatment, and research. As part of the Regional Health Service, it serves as the regional oncology reference center, developing and updating diagnostic and therapeutic pathways. The Institute conducts clinical and translational research through institutional and externally funded projects from national, regional, and charitable organizations.
The IOV – Veneto Oncology Institute – IRCCS is the first institute in the Veneto region specifically dedicated to the prevention, diagnosis, and treatment of tumors and to cancer research. Its mission is to provide the most advanced care to cancer patients while simultaneously conducting biomedical research, essential for advancing knowledge and providing patients with the most innovative treatments.
Lab4Paws is a CRO and research tool provider advancing veterinary and human preclinical research. We deliver high-quality biospecimens, PBMCs, and matched data, while developing 3D cell models for drug discovery and toxicology studies. With unique access to veterinary clinical networks, we help pharma and biotech accelerate innovation with reliable, species-relevant tools.
Since 2014, MCE CARREL has pursued a vision of law that is resolutely focused on innovation, rigour, operational action and strategy. The firm has built up recognized expertise in structuring, securing and developing complex technological and scientific projects in a variety of sectors.
We are involved at all stages of the innovation cycle and have developed scientific skills in areas where expertise alone is not enough and must be backed up by real experience in the field.
Empower your product data.
Medipim is the all-in-one international PIM solution for the pharmacy and biotech industry — connecting manufacturers, distributors, and e-commerce platforms.
Easily manage and sync high-quality data and images for Rx and OTC products, updated daily and shared seamlessly across the entire pharmaceutical ecosystem.
Our tox team is strong in non-clinical/toxicological/safety assessment of human products (especially in non-rodent species) and safety and BEQ assessment of veterinary products. We are one of a very few European facilities providing studies on cats and dogs according to VICH guidelines (new products, new therapies and generic products). Specific validated animal models are available (osteoarthritis, chronic glaucoma, human influenza). We are GLP-certified, CIR-certified, OLAW accredited.
About Menarini Biotech srl
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-
As a mid-sized CDMO, we provide tailored pharmaceutical solutions with 13 sites in France, Spain, and Sweden (including development sites). From concept to commercialisation, we support your therapy with expertise in sterile multidose and injectables, lyophilisation, sachets, stick packs, and oral or semi-solid forms. We are your dedicated partner in development and manufacturing, solving challenges proactively and helping you reach the summit of success.
Founded in 1989 and headquartered in Switzerland, Microsynth is a leading European company in the synthesis and analysis of nucleic acids. Our business is organized into three core areas:
With over three decades of experience, we are committed to providing high-quality, reliable, and timely products and services—supported by excellent customer service and competitive pricing.
miRoncol Health will launch the first-of-its-kind microRNA based mutli-cancer risk stratification blood test in 2026. The proof of concept studies demonstrated superior performance particularly for early stage cancers with ~90% sensitivity at 99%+ specificity among ~80% common solid tumors other than breast cancer. It outperforms mainstream ctDNA based tests and is also more affordable due to requiring only a few microRNAs and using widely available PCR technology.
Mitologics is a biotechnology company specializing in mitochondrial dysfunction and bioenergetic analysis. We offer predictive toxicity and efficacy screening using isolated mitochondria and cultured cells. Our assays, validated on mouse and human liver mitochondria, deliver proven predictive value for human hepatotoxicity. Mitologics also perform MoA studies for oncology, cardiovascular, metabolic, and neurodegenerative research, including customized potency assays for cell and gene therapy.
With 270 employees, Mora is a high-tech industrial group specialized in the production of thermoplastic injected parts for the medical, automotive and defence sectors.
We support our customers in the development and industrialization of complex projects. Our customers also benefit from our expertise in peripheral processes complementing the injection process, such as assembling subassemblies, decoration, packaging and the control of outsourced operations (sterilisation for example).
MP Biomedicals is a leading global life science company headquartered in California, with a strong international presence
through regional offices worldwide. We offer an extensive portfolio of life science products, fine chemicals, and diagnostics,
serving diverse markets including academic research, hospitals, clinical diagnostics, biotechnology, pharmaceuticals, and
various industries.
NEBULA is a deeptech company revolutionizing drug discovery through a proprietary generative AI and physics-based platform that reveals hidden, “undruggable” pockets within any therapeutic target. Unlike traditional AI players that focus on screening known sites, NEBULA operates upstream, unvealing new druggable conformations and accelerating the discovery of transformative therapeutics. Its in silico, data-free approach enables faster, more cost-efficient drug design without heavy experimental infrastructure. With validated proof-of-concept on KRAS-mutant targets, NEBULA aims to become a strategic R&D partner for pharma and biotech companies seeking novel opportunities across oncology and other high-impact therapeutic areas.
Neolie Science Partners supports biotech, health, and cosmetics companies through strategic consulting, business development, and project management. We help define market positioning, secure funding and partnerships, and coordinate product development with regulatory alignment (FDA, SCCS, EMA).
NEB is a key supplier of reagents for the life science industry since 1974. NEB offers a wide range of innovative enzymes, reagents and kits for molecular biology.
The quality of our solutions (ISO 9001/13485, RUO or GMP-grade) and our capabilities make NEB the partner of choice to support needs associated with the development of MDx, vaccines or therapies.
Come and discuss with our team about your customization, bulk/OEM, kitting or lyophilization needs.
With more than 30 years of experience in pre-clinical, clinical development and clinical trial services, Nextpharma can provide support and expertise for the development of your new small molecule in various dosage forms. First in Human with pure API in capsules using our Xcelodose equipment to go quick to clinic. Lipid Based formulation for poorly soluble or permeable compound or to reduce food effect. For the formulation of your NCE, NextPharma will guide you towards the right technology.
Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery, combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities. We work collaboratively with our clients to meet their scientific challenges and translate breakthroughs into new medicines that expand the possibilities of human health.
Ooho is a life sciences marketing agency helping biotech, medtech and service providers bring innovations to market faster through branding, content and lead generation. With in-house scientists, digital marketers, and creatives, we operate as an extension of your team: low-touch, high-output. Trusted by over 70 clients globally. Ooho has a strong presence across Europe and North America.
OPIS is a global full-service CRO with 26+ years of experience across all clinical phases and therapeutic areas. With 1,500+ studies managed in 18 countries, we provide end-to-end support—from study design and execution to data management and reporting advancing global clinical research through scientific excellence and operational expertise.
ORINOVA is developing a breakthrough innovation in oncology with a patented nanomedicine incorporating a unique dual therapy: a chemotherapy molecule combined with gold nanoparticles. This combination amplifies the effect of radiotherapy, optimizes the efficacy of chemotherapy and enables tumors to be targeted via intra-tumoral administration, thus limiting side effects for patients. This intelligent nano-object could revolutionize the treatment of particularly resistant solid tumors as GBM.
Paris-Saclay offers an exceptional density and variety of potential partners and resources, ranging from the multidisciplinary laboratories of Université Paris-Saclay and Institut Polytechnique de Paris to industrial players in strategic economic sectors, and from the large shared scientific facilities and infrastructures to the network of incubators and innovation places.
PerfeTTO is the first Italian Network of Technology Transfer Offices (TTO) in Life Sciences, funded by the Italian Ministry of Health.
Comprising 54 entities, including research hospitals, universities, and research institutions, PerfeTTO aims to bridge the gap between research and innovation. It focuses on developing services, tools, and resources to promote technological development, enhance the global value of Italian scientific research, and foster a national culture of technology transfer.
PhinC Development is a French Contract Research Organization (CRO) specializing in clinical pharmacology and modeling & simulation. We support biotechs and pharma companies in optimizing drug development, from early stages to clinical trials, with innovative, tailored solutions. Our expertise helps reduce risks, time, and costs in bringing new therapies to patients.
PMC Isochem, a French expert in fine and pharmaceutical chemistry, turns your ideas into industrial success. With PMC R&D Services, access a one-stop hub combining biology, formulation, chemistry, and analytical development. Our team of experts designs tailored and innovative solutions to accelerate your developments and support your projects.
PMT Santé brings together industrial companies, research laboratories, and the academic world in the health sector of Bourgogne-Franche-Comté. It supports the French medical device industry, promotes the health sector in the region, and contributes to the development of the French bioproduction sector. The cluster is firmly anchored in the medicine of the future and fosters projects linked to two main areas:Medtech players with a strong network of subcontractors offering the possibility to devel
PolyPeptide Group is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages. Its broad portfolio reflects the opportunities in drug therapies across areas and with a large exposure to metabolic diseases, including GLP-1. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India.
Porsolt is specialized in preclinical development with an expertise in various areas (CV,CNS…). We offer tailored solutions with in vitro, and in vivo models accross the use of many species (dog, rat, minipig…), biomarker analysis and histology for enhanced study data. Let’s discuss!
PPRS is a specialized firm providing R&D services for pharmaceuticals and medical devices. In drug development, we offer end-to-end support from discovery to regulatory approval, with expertise in neuroscience and orphan diseases. We developed the Somno-Art, an ambulatory medical device for automatic sleep architecture analysis, aid to diagnostic and therapeutic monitoring intended for medical use and clinical research.
ProteoGenix is a French Contract Research Organization (CRO) founded in 2003 and based near Strasbourg. It is recognized as a major player in the biotech field, providing integrated services from discovery to clinical phases, with a strong focus on the development of therapeutic and diagnostic antibodies.Complementing its services, the company also offers an online shop to support scientists with ready-to-use reagents worldwide.
Stability storage is part of the quality assurance process for pharmaceutical and medical device products. With walk-in rooms and reach-in cabinets that are fully validated and monitored, Q1 Scientific can store your samples at any ICH or custom temperature and humidity condition, from -80°C ultra-low freezer storage to over +50°C. Operating from state-of-the-art GDP facilities in Belgium, Q1 Scientific helps improve the speed of new drugs and medical devices reaching the marketplace along with saving companies the expense of building and monitoring their own storage chambers.
Qfluidics redefines continuous-flow chemistry with a breakthrough reactor capable of handling solids, slurries, and viscous media while ensuring precise and consistent mixing.
This innovation unlocks a new level of process performance, reducing waste, energy, and raw material consumption, improving PMI and carbon footprint, and optimizing costs across development and production.
It delivers greater reliability, fewer unplanned stops, and higher productivity.
By enabling clean, local, and economically viable manufacturing, Qfluidics makes sustainable production a source of competitive advantage.
We empower fine chemical and pharmaceutical companies to innovate faster, more efficiently, and more responsibly.
Quality Assistance is a leading European CRO focused on analytical sciences for innovative drug development. Based in Belgium and GxP-certified, the company provides EMA- and FDA-compliant services from a fully integrated, single-site facility equipped with a comprehensive suite of state-of-the-art technologies. With over 40 years of experience and 280 professionals, it supports the development of complex modalities such as biologics, nanomedicines, mRNA, and cell and gene therapies.
RD-Biotech is a french CRO/CDMO providing tailor-made development and production services: plasmid DNA, monoclonal antibodies, recombinant proteins and antibodies, cell lines.
Our technological platforms, our capabilities and our expertise allow us to meet your needs to support you in your research, preclinical and clinical projects, up to large-scale batches (several grams) with a requested quality grade: Research, High Quality and GMP (for pDNA exclusively)
ISO 9001:2015 certification & CIR
In just a few decades, Luxembourg has built a competitive, innovation-driven research ecosystem. Research Luxembourg is a joint initiative of our main public research actors. At BioFit/MedFit, our delegation will include the Luxembourg Centre for Systems Biomedicine-LCSB (medicine, computational sciences), the Luxembourg Institute of Health-LIH (biomedical research, personalised healthcare), the Luxembourg Institute of Science and Technology-LIST (smart biomaterials, nanotechnologies).
Deeptech startup of Biotechnology, our goals are to understand the Physiology & the Physiopathology of the Central Nervous System (CNS) to find the future therapeutic molecules against neurological diseases (neurodegenerative and cancer) and study the impact of the environment on the CNS.
For that, we provide preclinical biological systems of CNS to dissect molecular, cellular & tissular mechanisms in a physiological 3D-living tissue environment, & which reduce animal test in research.
Réseau LiEU operates as a knowledge transfer network under Wallonia-Brussels International (WBI). It connects the knowledge transfer offices (KTOs) of universities within the Wallonia-Brussels Federation to foster collaboration between academic researchers and the private or public sectors. This network serves as a centralized portal to facilitate partnerships, access academic expertise, and promote innovation and research commercialization in Belgium and abroad.
RheaVita markets an innovative continuous freeze-drying technology for (bio)pharmaceutical products. Our manufacturing approach saves you time and money, guarantees your product quality and offers your operations greater flexibility, compared to traditional batch freeze-drying. RheaVita sells single vial units for R&D, and full GMP systems.
RLM Consulting provides a wide range of regulatory affairs supports for the development of disruptive IMP/IND, from early nonclinical development to the late phases of clinical development. We aim to accelerate your journey with the best regulatory pathway in the EU and USA. Our consultants, all highly skilled in science and regulatory affairs can guide you on the CMC, nonclinical and clinical requirements. We act as an applicant for various submissions, and we write your dossier.
Rombio: an AI-powered production planning & scheduling solution.
Rombio transforms planning into performance.
Powered by artificial intelligence, Rombio delivers smart, optimized schedules that align with your KPIs, resources, and business constraints.
Gain full visibility over your operations, anticipate future needs, and make decisions with confidence.
SATEC is a French insurance broker (380 employees) with about 250 Life Sciences companies as clients: biotechs, medtechs, pharmas, medical devices, CROs, CDMOs, …
We offer a broad range of tailored insurance solutions which include: clinical trials, liabilities, supply chain, property and business interruption, cyber risks, directors & officers, intellectual property, …
Through licensing agreements and plant-based production, Serendip combines its plant-derived nanotechnology with partners’ therapeutic compounds to improve efficacy, tolerance, and production costs. This non-viral, thermostable, and naturally low-immunogenic carrier (also called vector) can transport proteins, peptides, and RNA while enabling precise molecular and cellular targeting. For the next generation of therapeutics, Serendip’s technology offers a safe, efficient, and scalable delivery platform. Proof of Concepts are being generated with antigens, cytotoxic and immuno-stimulant molecules.
SGS Vitrology (Glasgow): As a world leader in biopharmaceutical testing services, we offer you a comprehensive range of biologics safety testing, including virology, cell and molecular biology, as well as microbiology and electron microscopy. As a result, we can help you to ensure product safety and meet your regulatory requirements.
The French Association for the Animal Health Industry (SIMV) represents companies that design, manufacture and market veterinary medicines and diagnostic reagents for both companion and farm animals within the French market.
To enhance the competitiveness of its members, SIMV focuses on five core missions:
As a trusted CRO, our experience and knowledge in tackling complex clinical trials is extensive. Our history over the past 20 years shows a breadth of expertise across a wide variety of indications. Not only are we trusted industry experts within clinical trials for orphan diseases, pediatrics, and medical devices, but we have deep experience in other therapeutic areas as well, Oncology, Dermatology, Cardiology Pulmonology, and more.
Spartners by Servier & BioLabs is on a mission to empower life science innovation in Paris-Saclay by creating a unique place for life science startups to test, develop and grow game changing ideas.
Spartners offers fully equipped laboratory and office spaces that are supported by an experienced, dedicated, technical team. Designed to build community, Spartners enables high-potential life science companies to work, collaborate and innovate in a setting perfectly suited to meet their needs.
Spectralys Biotech, a spin-off from the University of Brussels, provides analytical services for structural characterization of biopharmaceuticals. We leverage expertise in infrared spectroscopy (FTIR), atomic-force microscopy coupled with infrared (AFM-IR), circular dichroism, and hydrogen-deuterium exchange monitored by mass spectrometry (HDX-MS). FTIR enables analysis of higher-order structures in proteins and nucleic acids, while HDX-MS is powerful for applications such as epitope mapping.
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global biopharma, nutrition, animal health, consumer goods, and specialty chemical sectors. With 5600 world-class scientists and 2.2 Mn sq. ft specialist facilities, Syngene offers skills and capacity to improve time-to-market and lower the cost of innovation.
Syngulon is a synthetic biology company that engineers bacteriocins – ribosomally-produced, genetically-encoded antimicrobial peptides for:
• Antibiotic-free genetic selection – Proprietary bacteriocin/immunity cassettes replace traditional antibiotic-resistance markers in recombinant protein and plasmid-DNA manufacturing
• Next-generation antimicrobials – Engineered bacteriocins as stand-alone or adjunct therapeutics to combat antimicrobial-resistant (AMR) pathogens in human health
Specializing in the design, industrialization and manufacture of active medical devices on a subcontracting basis, Tame-Care supports you at every stage of your project and throughout its lifecycle.
Thanks to our expertise in electronic, mechanical and software engineering, we have all the skills needed to develop your most innovative medical devices.
As part of AGÔN Electronics, a major French industrial group, we can also ensure the mass production of your device.
Tekies is an innovation partner focused on developing AI solutions tailored to specific clients needs. We empower companies to adapt, grow, and lead through intelligent automation, forecasting, computer vision, and digital assistants. Our platform Floxgen accelerates genomic data analysis, helping biotech teams unlock insights in record time. With crosssector expertise, we turn complex challenges into scalable, real world impact.
Our science park offers an efficient environment for innovation in the fields of medical devices, biodrugs and bioproduction.
CDMOs, Engineering and Clinical investigation centers, cleanrooms, bioproduction capacities, biological materials, technological platforms, and the EFS industrial integrator are available for your projects from proof of concept to market launch, supported by scientific and regulatory expertise.
Advesya, Affluent Medical, Carl Zeiss Meditec, Carla, EOS Imaging, Oragen
The smart manufacturing industry (High Tech Systems and Materials) is characteristic for the Twente region in East-Netherlands. The World Trade Center Twente is building a MedTech cluster together with the Techmed Center at the University and companies in the medical technology sector.
Unither Pharmaceuticals is the world leader in the production of sterile unit-doses. This international CDMO develops and manufactures health products in its plants in France, the United States, Brazil and China. It specializes in liquid forms, both sterile and non-sterile. As Unither has grown since its founding in 1993 in Amiens (France), the company has deployed global solutions including co-development, technology platforms, and a deep understanding of markets.
The University of Liège (ULiège) is an international university at the heart of Europe, home to a vibrant multicultural community across four campuses. Its Research, Innovation, Support and Enterprise department (RISE) enhances research and innovation by supporting researchers, managing projects and funding, protecting and commercializing results, fostering collaborations, and creating spin-offs that drive socio-economic and environmental impact.
The Université libre de Bruxelles (ULB) is a multicultural university fosteIts Knowledge Transfer Office (ULB-KTO) drives research and innovation by supporting PhD and postdoctoral work, guiding researchers in funding and partnerships, protecting intellectual property, and promoting technology transfer through spin-offs and collaborations that maximize socio-economic impact. ring global collaboration. Supported by Wallonia, FEDER and Innoviris.
VETBIOLIX is a VC-backed, clinical-stage, veterinary biotech company dedicated to the development of First-in-class drug candidates for osteoarthritis (OA), periodontitis (PD) and gut motility disorders. VETBIOLIX is currently leading 2 EU-multicentric, Pilot, randomized, double-blind, dose-ranging, placebo-controlled clinical studies in canine OA (VBX-2000 – A-A3 ag.) and canine PD (VBX-1000 – Cath-K Inh.), and 2 Proof of concept clinical studies in canine / feline GMD (VBX-3000 – 5-HT4 ag.).
Founded in 1982, Véto-pharma is a French, GMP & HACCP certified, pharmaceutical laboratory, specializing in animal health. As a CDMO player, Véto-pharma develops and manufactures veterinary medicines, food supplements, hygiene and care products for pets and farm animals, and supports its customers throughout the entire development and manufacturing process for their own brands. Its industrial site covers 10,000m² and includes 3 production workshops: non-steril liquids, semi-solids and solids.
Wallonia-Brussels International (WBI) is the organization responsible for the international relations of Wallonia-Brussels.
With its network of Scientific and Academic Advisors (SAA), the Research & Innovation Department (R&I) of WBI is the focal point for all institutions and actors in R&I wishing to connect with other innovative regions around the world. In France, the SAA, Adrien Sellez, is based in Paris.
Founded in 2012, X’PROCHEM is a CRO (Contract Research Organization) specializied in chemical protein synthesis.
We design and produce therapeutic proteins for our pharmaceutical and biotech partners. We manufacture complex and highly customized proteins up to 400 amino acids (40 kDa) by using an automated process.
Zerion Pharma A/S is a Danish pharmaceutical company aspiring to transform the pharmaceutical landscape for the formulation of poorly soluble drugs. Its pioneering Dispersome® technology greatly enhances the solubility, bioavailability, and therapeutic potential of oral drugs. Based on the novel excipient beta-lactoglobulin (BLG), Dispersome® enables stable, high-load amorphous formulations that improve patient outcomes.
Zoetis is the world’s leading animal health company. Our purpose is to nurture our world and humankind by advancing care for animals. After more than 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. A Fortune 500 company, we generated revenue of $8.5 billion in 2023 with ~14,100 employees. For more, visit http://www.zoetis.com
